<DOC>
	<DOC>NCT01285544</DOC>
	<brief_summary>There will be no significant differences in the efficacy and tolerability between the test and reference formulations of atorvastatin 20 mg in these Korean adults with primary hypercholesterolemia.</brief_summary>
	<brief_title>The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>the patients aged 20 to 79 years with primary hypercholesterolemia that was not sufficiently responsive to therapeutic lifestyle changes and had LDLC level over 100 mg/dL in high risk group. Inclusion criteria was in accordance with drug treatment guidelines; coronary artery disease or equivalent group with LDLC ≥100 mg/dl; patients with two or more risk factors and LDLC≥130 mg/dl; patients with 0 or 1 risk factor and LDLC &gt;160 mg/dl after therapeutic lifestyle changes therapy with any other investigational drug within 30 days of randomization, history of hypersensitivity to HMGCoA reductase inhibitors, uncontrolled hypertension, poorly controlled diabetes (glycosylated hemoglobin [HbA1c] &gt;9%), unstable angina or presented with newonset myocardial infarction (within 6 months), creatinine &gt;2.5 mg/dl, alanine aminotransferase (ALT) &gt;2 x upper limit of normal (ULN), aspartate aminotransferase(AST) &gt;2 x ULN, or creatine kinase (CK) &gt;2 x ULN, history of malignancy or psychosis; chronic liver disease, drug or alcohol abuse, pregnancy, breastfeeding, failure to practice adequate contraception, cyclical hormonal contraceptives or intermittent use of hormone replacement therapies.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>statins</keyword>
	<keyword>cholesterol</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>Dyslipidemia in cardiovascular disease (KoLipinon)</keyword>
</DOC>